Mereo BioPharma Ratios (2020-2025) | MREO

Ratios Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 61.89%127.30%80.00%
EBT Margin -19.46%-964.10%7,159.44%-2,923.20%
EBIT Margin -9.01%-712.80%6,223.33%-2,099.80%
EBITDA Margin -3.90%-500.60%5,182.22%-1,593.80%
Operating Margin -9.01%-712.80%6,223.33%-2,099.80%
Net Margin -19.46%-910.90%7,159.44%-2,923.20%
FCF Margin -86.16%-678.90%4,638.33%-1,530.20%
Efficiency
Assets Average 109.72M142.84M186.48M153.23M106.73M61.22M76.03M92.44M82.57M72.36M65.48M58.12M
Equity Average 103.13M69.52M46.69M60.74M75.59M66.75M60.52M57.13M50.39M
Invested Capital 21.31M138.02M87.63M51.89M50.54M42.84M78.65M72.54M60.97M60.08M54.18M46.60M
Asset Utilization Ratio -0.01-0.01-0.02-0.020.160.010.010.000.000.01
Leverage & Solvency
Interest Coverage Ratio -14.26-0.79-12.95-20.19-31.94-38.71-26.55-40.73-62.23-437.46-357.68
Debt to Equity 0.160.230.01
Debt Ratio 0.130.260.120.110.150.01
Equity Ratio 0.700.640.660.760.770.820.820.800.880.870.87
Times Interest Earned -14.26-0.79-12.95-20.19-31.94-38.71-26.55-40.73-62.23-437.46-357.68
Valuation
Enterprise Value -20.30M-30.99M-32.80M-127.11M-118.75M-68.18M-57.42M-48.70M-87.43M-80.52M-69.80M-62.50M-56.12M-48.70M
Return Ratios
Return on Sales -0.19%-2.26%-9.11%-2.63%-36.85%-45.32%71.59%-29.23%-129.92%
Return on Capital Employed -0.54%-0.64%-0.50%-0.69%-0.75%-0.80%-0.90%
Return on Invested Capital -0.56%-0.63%-0.51%
Return on Assets -0.43%-0.48%-0.49%-0.52%-0.65%-0.76%-0.72%
Return on Equity -0.56%-0.61%-0.60%-0.65%-0.78%-0.87%-0.83%